Table 4 Patient characteristics according to the presence of fibrosis in the gastrointestinal tract.

From: Capsule endoscopy findings reflect the gastrointestinal conditions of patients with systemic sclerosis

Variables

Fibrosis

P-values

(+), n = 17

(−), n = 38

Female

14 (82)

37 (97)

0.0586

Subclassification (dcSSc)

10 (59)

17 (45)

0.3333

Mean age (y. o.)

68.7 [58–81]

62.7 [36–80]

0.3568

Medication

Anti-platelet drugs

3 (18)

4 (11)

0.3486

NSAIDs

2 (12)

6 (16)

0.6771

Chief complaint

Abdominal symptoms

5 (29)

10 (26)

 

OGIB

2 (12)

11 (29)

 

No symptoms

10 (59)

17 (45)

 

mRSS

13.9 [0–43]

9.4 [0–34]

0.1623

Telangiectasia

5 (29)

10 (26)

0.8117

Disease duration (month)

56.6 [10–120]

65.8 [7–192]

0.4783

  1. Data are shown as frequencies (percentages) or means, as appropriate.
  2. SSc: systemic sclerosis, dcSSc: diffuse cutaneous SSc, NSAIDs: non-steroidal anti-inflammatory drug, OGIB: obscure gastrointestinal bleeding, mRSS: modified Rodnan’s total skin thickness score.
Back to article page